Challenges To Developing High Concentration Formulation For MultiSpecific Antibodies
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=9RAUMf4wYPM
During the Bioprocess Online Live event Process Development For A Diverse mAb Pipeline, Bayer’s Sr. Director, Bioprocess Technologies Amir Goudarzi, Ph.D. answered audience questions on overcoming challenges in high-concentration anitibody formulations, while simultaneously maintaining purity. • Check out the full webinar available on-demand thanks to the support of Cytiva - https://www.bioprocessonline.com/doc/...
#############################
![](http://youtor.org/essay_main.png)